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Key Messages
• Colonic transit tests are often useful in managing functional gastrointestinal disorders (FGIDs).
• We used serial MRI to assess orocecal transit (OCTT) of the head of a test meal and the position of water filled
capsules taken 24 hours before as markers of whole gut transit (WGT).
• The new MRI techniques were compared with the Lactose Ureide breath test to measure OCTT and the
Radioopaque Marker (ROM) method to measure the WGT.
• The MRI marker capsule technique compared favorably with the standard ROM method for measuring WGT
and being non-invasive and non-ionizing, has significant advantages in patients with FGIDs, many of whom are
young females.
Abstract
Background Colonic transit tests are used to manage
patients with Functional Gastrointestinal Disorders.
Some tests used expose patients to ionizing radiation.
The aim of this study was to compare novel magnetic
resonance imaging (MRI) tests for measuring orocecal
transit time (OCTT) and whole gut transit time
(WGT), which also provide data on colonic volumes.
Methods 21 healthy volunteers participated. Study 1:
OCTT was determined from the arrival of the head of
a meal into the cecum using MRI and the Lactose
Ureide breath test (LUBT), performed concurrently.
Study 2: WGT was assessed using novel MRI marker
capsules and radio-opaque markers (ROMs), taken on
the same morning. Studies were repeated 1 week later.
Key Results OCTT measured using MRI and LUBT
was 225 min (IQR 180–270) and 225 min (IQR 165–
278), respectively, correlation rs = 0.28 (ns). WGT
measured using MRI marker capsules and ROMs
was 28 h (IQR 4–50) and 31 h  3 (SEM), respectively,
correlation rs = 0.85 (p < 0.0001). Repeatability
assessed using the intraclass correlation coefficient
(ICC) was 0.45 (p = 0.017) and 0.35 (p = 0.058) for
MRI and LUBT OCTT tests. Better repeatability was
observed for the WGT tests, ICC being 0.61 for the
MRI marker capsules (p = 0.001) and 0.69 for the
ROM method (p < 0.001) respectively. Conclusions &
Inferences The MRI WGT method is simple, conve-
nient, does not use X-ray and compares well with the
widely used ROMmethod. Both OCTT measurements
showed modest reproducibility and the MRI method
showed modest inter-observer agreement.
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Abbreviations: AQR, acquired resolution; AXR, abdom-
inal X-ray; DOTA, 1,4,7,10-tetraazacyclododecane-
1,4,7,10-tetraacetic acid; FA, flip angle; FFE, fast field
echo; FGIDs, functional gastrointestinal disorders; FOV,
field of view; ICC, intraclass correlation coefficient;
IQR, inter-quartile range; LUBT, Lactose Ureide breath
test; MIP, maximum intensity projection; MMC,
migrating motor complex; MRI, magnetic resonance
imaging; OCTT, orocecal transit time; ROMs, radio-
opaque markers; SBWC, small bowel water content;
SEM, standard error of the mean; TE, echo time; TR,
repetition time; TSE, turbo spin echo; WGT, whole gut
transit time.
INTRODUCTION
Functional gastrointestinal disorders (FGIDs) account
for ~40% of all gastrointestinal secondary care refer-
rals, so efficient diagnosis is important.1 The com-
monest diagnoses are functional constipation,
functional diarrhea, and irritable bowel syndrome.2
Currently, diagnosis is based on reported symptoms,
which can sometimes be unreliable, particularly when
assessing reported constipation.
Objective measurements of transit are currently the
best validated biomarkers to guide treatment3 and
predict drug effectiveness.4 There are a variety of tests
which have been developed to measure the orocecal
transit time (OCTT) with gamma scintigraphy, imag-
ing the small bowel transit of a tracer, considered as
the gold standard.3 This method is limited in use as it
is costly, poorly standardized, and exposes the patient
to ionizing radiation which would limit its repeated
use. In our study, we used two alternative methods to
measure OCTT, the Lactose Ureide breath test (LUBT)
and magnetic resonance imaging (MRI), both of which
have the advantage of not using ionizing radiation.
There are also a number of techniques used to measure
whole gut transit time (WGT), which is dominated by
the time to transit the colon. These include radio-
opaque markers (ROMs),5 scintigraphy,6 magnetic
marker monitoring,7 wireless motility capsule,8 and
fluorine-19 labeled MRI markers.9 While each method
has its unique advantages most have not become
widely adopted in clinical practice due to their own
particular limitations.10 The Metcalf ROM method is
probably most widely used in hospitals to assess WGT.
Although it is simple and inexpensive, given that a
substantial proportion of patients in whom such tests
are indicated are females of child-bearing age, a major
drawback of the ROM method is that it exposes to
ionizing radiation. Magnetic resonance imaging can
overcome some of these limitations and potentially
offer tests which could be widely adopted and benefit
from being non-invasive and avoid ionizing radiation.
The aim of this study was to validate two novel MRI
based methods, one for measuring OCTT and one for
measuringWGT and also to assess their reproducibility.
We also took advantage of the extra capabilities of MRI
to examine the relation between bowel habit, colonic
volumes, and transit time in healthy volunteers.
MATERIALS AND METHODS
The subjects participated in two separate test–retest open label
studies. Study 1 to compare an OCTT MRI method against the
LUBT and Study 2 to compare a WGT MRI method against the
widely used Metcalf ROM method. This protocol was registered
with ClinicalTrials.gov identifier: NCT01534507. The studies
were approved by the National Research Ethics Service (REC
number 11/EM/0245); all volunteers gave written informed
consent. The studies were carried out according to Good Clinical
Practice principles.
Subjects
Twenty-one healthy subjects (12 males, 9 females; 21–70 years)
were enrolled and took part in both studies. Subjects with any
previous history of gastrointestinal disease, or taking any medi-
cation known to alter bowel motility were excluded from the
study. All subjects completed a MRI safety questionnaire, to
exclude persons with contraindications to MRI, and a hospital and
anxiety scale questionnaire. All of the 21 volunteers completed
Study 1, which was repeated after a 1 week washout period, to
assess reproducibility of the tests. 20 of the same 21 volunteers
completed Study 2, also repeated after a 1 week washout period,
to assess reproducibility.
STUDY 1: OROCECAL TRANSIT TIME
(OCTT)
MRI OCTT test
Subjects attended at 08:00 am after an overnight fast
and underwent a baseline MRI scan before being fed a
mixed solid/liquid test meal as used in previous
studies.11 This consisted of: 220 g creamed rice pud-
ding (J Sainsbury plc, London, UK), 34 g seedless
strawberry jam (J Sainsbury plc), uniformly mixed with
15 g course wheat bran (Holland and Barrett, Hinkley,
UK), and a glass of 100 mL orange juice from concen-
trate (J Sainsbury plc) providing a total of 362 Kcal.
Subjects were scanned every 45 min for a total of 8.5 h.
They were fed a second 1000 Kcal meal at 6.5 h
which consisted of: 400 g microwaveable macaroni
cheese ready meal (J Sainsbury plc), 100 g strawberry
© 2013 The Authors.
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cheesecake (J Sainsbury plc) and 250 mL bottled still
water (J Sainsbury plc). Magnetic resonance imaging
scanning was carried out on a 1.5 T Philips Achieva
scanner, using a 16 channel XL torso coil. Subjects
were scanned in a supine position and in between
scans volunteers sat in an upright position in the
waiting room. The arrival of the head of the meal into
the cecum was determined from images acquired using
a dual-echo 2D multi-slice FFE sequence (Echo Time 1
[TE1] = 4.6 ms; Echo Time 2 [TE2] = 6.9 ms; Repetition
Time [TR] = 212 ms, Flip Angle [FA] = 80°). 24 coronal
images were acquired to cover the abdomen with an
acquired voxel size of 2.01 9 2.87 9 7.00 mm3 (recon-
structed voxel size of 1.76 9 1.77 9 7.00 mm3), a field
of view [FOV] of 450 9 360 mm2, and a slice thickness
of 7 mm with no gaps (SENSE factor = 1.7). Images
were acquired during a breath hold of 17 s. An
additional single shot turbo spin echo (TSE) sequence
was acquired to measure small bowel water content
(SBWC)12 which meant subjects spent ~10 min inside
the magnet for each time point.
The arrival of the head of the rice pudding meal was
assessed visually using the 2D FFE images. We
estimated the OCTT as the time from the firsts scan
to show entry of bolus of high intensity material into
the ascending colon which prior to this event had
mostly a low intensity on the images. We also used the
2D FFE images to measure colonic volumes before
(t = 360) and after (t = 405) the high calorie meal, as it
has been implied before that clearance of the ascending
colon may correlate with overall transit time.13 We
measured colonic volumes at these particular time
points after the standard meals, rather than fasting, to
minimize differences which might relate to activity
and feeding patterns the day before. Although our
standard practice is to exclude certain foods likely to
alter transit this still leaves room for lots of difference
which might alter fasting volumes. Colonic volumes
were measured using the software Analyze© 9.0 (Bio-
medical Imaging Resource, Mayo clinic, Rochester,
MN, USA).
LACTOSE UREIDE BREATH TEST
We used a previously validated LUBT protocol.14 The
day before the test day subjects ingested 1 g (6 mmol)
of unlabeled Lactose Ureide (Euriso-top, Saint-Aubin
Cedex, France) three times a day with meals (morning,
afternoon, and evening), to stimulate bacterial enzyme
activity to cleave the Lactose Ureide in the colon. On
the test day the LUBT was performed alongside the
MRI OCTT test (described above) and subjects pro-
vided a baseline breath sample before being fed a
standard test meal (details above). The test meal was
mixed with 500 mg 13C labeled Lactose Ureide (Euriso-
top, Saint-Aubin Cedex, France). Breath samples were
taken every 15 min for 1 h and then every 10 min for a
further 9 h. A second high calorie meal was fed 6.5 h
after the test meal (details above). Breath samples were
analyzed using an IRIS-Lab analyzer machine (Wagner
Analysen Technik, Bremen, Germany). Results are
expressed as delta over baseline, which is the difference
between the ratio of 13CO2/
12CO2 in the post dose
breath sample and the corresponding ratio in the
baseline sample. The OCTT was taken as the time
post ingestion that the increase in breath 13C reached
2.5 times the SD of all previous above the running
average of all previous points (Fig. 1), as defined in the
LUBT validation study.14 The OCTT was automati-
cally determined from the breath data using an
Figure 1 13C breath excretion curve. Example 13C breath excretion
curve from Lactose Ureide Breath Test in one healthy volunteer with
indication of the orocecal transit time (OCTT). The OCTT is taken as
the time at which there is an increase in breath 13C which is 2.5 times
the SD of all previous points above the running average of all previous
points.
Figure 2 Magnetic resonance imaging (MRI) marker capsule. Example
of a capsule which consists of two polyoxymethylene half shells glued
together, and hand filled with 0.4 mL 15 lM Gadoteric acid (Gd-
DOTA). Leakage tests performed on 20% of each batch using a
spectrophotometer. Capsules have the dimensions of 20 9 7 mm.
© 2013 The Authors.
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in-house program written in Matlab (MathWorks,
Natick, MA, USA). The dose we used 6 mmol would
not be expected to exert a significant osmotic effect
and hence unlike lactulose, often used as a marker of
orocecal transit, would not be expected to alter transit.
STUDY 2: WHOLE GUT TRANSIT TIME
MRI WGT test
Subjects swallowed five MRI marker capsules
(20 9 7 mm) at 09:00 am, 24 h before undergoing an
MRI scan. The MRI marker capsules were all manu-
factured in-house using the biologically inert, Poly-
oxymethylene (Fig. 2). The capsules consist of two
half-shells which were glued together using cyanoac-
rylate superglue. A small hole had been drilled in the
top of one half-shell, so capsules could be hand filled
with 0.4 mL 15 lM Gadoteric acid (Gd-DOTA).
A small plastic screw was then inserted into the hole,
and glued with cyanoacrylate superglue to prevent
leakage. Spectrophotometry was used to asses leakage
on 20% of each batch of pills produced.
The MRI markers capsules were filled using the non-
toxic and biocompatible Gd-DOTA, which is a com-
plex of Gd3+ and the chelating agent DOTA. It is
routinely used in clinical practice as an MRI imaging
contrast agent, and its safety is well-documented. The
agent shortens the T1 relaxation times of protons it has
access to increasing the signal on T1 weighted images.
Preliminary work at our centre has shown that the
optimal concentration of Gd-DOTA to be used in the
capsules was 15 lM, which ensured that we obtain the
maximum signal intensity from the capsules on our T1
weighted images.15 This concentration was achieved
by diluting 1 mL of Gd-DOTA, at a concentration of
280 mg/mL, with 33 mL of distilled water.
Subjects were scanned in a 3 T Philips Achieva MRI
scanner using a multi-transmit body coil. Coronal
scans were obtained at two stations with a 30 mm
overlap using two different sequences. Firstly, a T1
weighted 3D TFE sequence (TE = 1.3 ms; TR = 2.9 ms,
FA = 10°, FOV = 250 9 398 9 160 mm3, Acquired
resolution [AQR] = 2.3 9 2.3 9 4 mm3), was used to
count and locate the number of capsules remaining in
the colon at 24 h. Secondly, a multi-echo FFE
sequence16 (TE1 = 1.07 ms; TE2 = 1.9 ms; TR =
3.0 ms, FA = 10°, FOV = 250 9 371 9 200 mm3,
AQR 1.8 9 1.8 9 3.6 mm3; SENSE factor = 2), using
a 16 channel XL torso coil to receive the signal, was
used to create a movie using the maximum intensity
projections (MIP) of the water only images (Fig. 3). The
movies allowed rotation of the colonic image giving 3D
visualization and were useful in clarifying the position
of the capsules at 24 h, if the T1 weighted TFE image
was not conclusive.
From the MRI images a transit score was calculated
by sub-dividing the bowel into eight sections (Fig. 4)
and each capsule was scored according to its position in
Figure 3 Maximum intensity projection (MIP) magnetic resonance
imaging (MRI) image. Showing five MRI marker capsules in the colon
(indicated by close arrows). Images created using water only images
acquired using the T1 weighted multi-echo FFE pulse sequence. Such
images were used to locate the number and position of capsules
remaining at 24 h to calculate a whole gut transit time.
Figure 4 Segmented Colon. Showing the segmented colon used to
score the MRI marker capsules at 24 h, where 0 = not found (presumed
to be excreted), 1 = sigmoid and rectum, 2 = descending colon, 3 = left
transverse colon, 4 = right transverse colon, 5 = upper ascending
colon, 6 = lower ascending colon, 7 = small bowel.
© 2013 The Authors.
Neurogastroenterology & Motility published by John Wiley & Sons Ltd.
208
G. Chaddock et al. Neurogastroenterology and Motility
the colon at 24 h. On several data sets 1 or 2 capsules
separated in position by several segments from the rest
of the capsules (visualized together in a group). To
reduce the effect of these outliers, due to the small
number of pills used (five capsules compared to 20
ROM/day), a weighting factor was calculated for each
capsule depending on the difference of the capsule
score from the median capsule score. For a difference of
0 and 1 the weighting factor was 1, for all differences
larger than 1 the weighting factor was the inverse of
the difference. A weighted mean position score of the
MRI marker capsules was thus determined for each
volunteer. A non-weighted least square fit was applied
to the MRI marker capsule scores and their corre-
sponding ROM transit scores to calculate a transit time
in hours for the MRI marker capsules. This is based on
the equation: y = mx + c (Fig. 6A). Where x is the
average MRI marker position, m and c are unique
coefficients determined from the validation study
(m = 0.03, c = 0.12), and y is the transit time in
hours.
STANDARD ROM TEST
The validated protocol described by Metcalf5 was used
in this study. Subjects swallowed 20 ROMs on three
consecutive days (days 1, 2, and 3) and an abdominal
X-ray was taken on the following morning (day 4)
immediately after an MRI scan, used to locate the MRI
marker capsules consumed the day before (day 3). The
ROMs were made of silicone tubing, impregnated
with 13.5% barium, with the dimensions of 2.42 9
5.09 9 1.6 mm (Altimex, Nottingham, UK). The WGT
was calculated in the standard way by counting the
number of ROMs remaining on day 4 and multiplying
by 1.2 to give a WGT in hours.
STATISTICAL ANALYSIS AND POWER OF
STUDIES
Statistics: For all data statistical analysis was carried
out using the software, Prism 5 (GraphPad Software
Inc, San Diego, CA, USA). The distribution of data
were tested using the D’Agostino and Pearson omnibus
normality test. The first primary outcome for this
study was the correlation between OCTT measure-
ments using the two test types. The second primary
outcome was the correlation between the WGT mea-
surements using the two test types. Since the data were
not normally distributed the Spearman’s rank correla-
tion coefficient test was used to assess correlations.
The secondary outcome for the study was to assess the
reproducibility of the different methods described and
we used the intra-class correlation coefficient test
(ICC) to assess this.
Power calculations: Using the data from Horikawa
et al.17 giving a mean colonic transit for healthy
volunteers of 35.7  12.9 h (mean  SD), we calcu-
lated that for 80% power to detect a 25% difference in
transit between the two methods, generally accepted as
approximately the minimal clinically important dif-
ference, we would need 19 subjects. We increased the
numbers to 21 to allow for dropouts and technical
problems.
RESULTS
All subjects completed both studies with no adverse
events, with the exception of one subject who did not
A
B
Figure 5 (A) Correlation between Lactose Ureide Breath Test (LUBT)
and magnetic resonance imaging (MRI). Scatter plot with line of
identity, comparing the orocecal transit time (OCTT) measured using
the LUBT and MRI. The degree of correlation was assessed using the
Spearman’s rank correlation coefficient test, and we report a
Spearman’s r-value of 0.28 (not significant). (B) Agreement between
OCTT measurements. Bland-Altman plot showing the average OCTT
measured using the LUBT and MRI on the x-axis, and the difference
between the OCTT measured using the two methods on the y-axis.
This plot shows that there was a mean difference of 7.32 min
between the LUBT and MRI (middle dotted line), with the limits of
agreement ranging from 183.0 to 197.6 min (upper and lower dotted
lines).
© 2013 The Authors.
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attend the X-ray appointments. The breath test data
from 1 volunteer, on visit 1, was omitted due to a high
level of noise within the data produced.
Comparison of the OCTT measured using the
LUBT and MRI
The median OCTT measured using the breath test was
225 min (IQR 165–278) and the median OCTT mea-
sured using the MRI based technique was also 225 min
(IQR 180–270). Fig. 5A shows that there was weak
correlation between OCTT measurements taken using
the two different methods (rs = 0.28, not significant).
The Bland Altman plot in Fig. 5B shows the limits of
agreement between the two methods. This graph
shows that although there is a small mean difference
of 7.32 min between measurements, the difference
between measurements ranges from 197.6 min to
183.0 min, as indicated by the upper and lower dotted
lines in Fig. 5B. There appears to be a tendency for the
difference between measurements to increase the
longer the transit time.
We used the ICC statistical test to assess the
repeatability of the two tests on two separate occa-
sions. The ICC for repeat OCTT measurement using
the LUBT and MRI was 0.35 (p = 0.058) and 0.45
(p = 0.017) respectively. We also examined the inter-
observer agreement between OCTT measurement
using our new MRI based method, which gave an
ICC of 0.44 (p = 0.002). Inter-observer agreement was
not measured for the LUBT OCTT results as measure-
ments were generated automatically using an in house
analysis program.
Comparison of the WGT measured using ROM
and MRI markers capsules
The mean WGT measured using ROMs was 31  3 h
(SEM), whilst the median average weighted position
score of the MRI marker capsules was 0.8 (IQR 0–1.6).
We used the regression equation linking the two
techniques to convert the average weighted capsule
scores at 24 h to a WGT in hours, giving a median
WGT of 28 h (IQR 4–50 h). Fig. 6A shows the correla-
tion between the two methods is reasonably good
(rs = 0.85, p ≤ 0.0001). The Bland Altman plot in
Fig. 6B shows the mean difference between WGT
measurements was 0.005 h, with a range from
25.69 to 25.68 h as indicated by the upper and lower
dotted lines on the plot in Fig. 6B.
The ICC for WGT values obtained on two separate
study days using the ROMs and MRI marker capsule
methods was also reasonable at 0.69 (p ≤ 0.001) and
0.61 (p = 0.001) respectively. We also examined the
inter-observer agreement between WGT measure-
ments using the ROM and MRI marker method, giving
an ICC value of 0.995 (p ≤ 0.001) and 0.78 (p ≤ 0.001)
for the two tests respectively.
In addition to measuring transit times, we used the
2D FFE MRI images obtained in study 1 to measure
volunteers’ colonic volumes (regional and total), both
before and after a meal. In addition, we used single shot
TSE images to assess SBWC as previously described
and validated.12 In summary, we found no significant
correlations between colonic volume, SBWC, and
transit time (both OCTT and WGT; Table 1). In
addition, we found no significant correlation between
transit time (both OCTT and WGT) and volunteer
A
B
Figure 6 (A) Correlation between radio-opaque markers (ROM) and
magnetic resonance imaging (MRI) markers. Plot comparing the whole
gut transit time (WGT) measured using ROMs and MRI marker
capsules showing the line of best fit as y = 0.03x  0.12. The degree of
correlation was assessed using the Spearman’s rank correlation
coefficient test, and we report a Spearman’s r-value of 0.85
(p < 0.0001). (B) Agreement between WGT measurements. Bland-
Altman plot showing the average WGT measured using the ROMS and
MRI marker capsules on the x-axis, and the difference between the
WGT measured using the two methods on the y-axis. This plot shows
that there was a mean difference of 0.005 h between test types
(middle dotted line), with limits of agreement ranging from 25.68 to
25.69 h (upper and lower dotted lines).
© 2013 The Authors.
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demographics such as gender, BMI, anxiety, depression
although there was a weak correlation between age and
OCTT (Table 1). Although most studies find females
to have slightly slower transit there is huge overlap and
in our study males and females had very similar transit
times median (IQR) 27.6 (3.7–45.4) and 25.6 (3.7–58.8)
hours, respectively, p = 0.7.
DISCUSSION
When analyzing the data we found no difficulty in
identifying the capsules in the MRI images and using
the 3D rotating MIP movie the exact position of each
capsule could be readily clarified if not conclusive from
the T1 weighted TFE image. This is rather different
from the ROM method when it can be difficult to
identify the precise site of the ROMs located in the
pelvic region on a plain X-ray.
Weused amethod toquantify theWGTsimilar to that
used for tracer dispersion in scintigraphic images when
quantifying colonic transit.18However, the novel aspect
of our MRI marker analysis is that the formula used to
calculate the transit time takes into consideration the
spread of the marker capsules position along the gut by
looking at the difference of each capsule position from
the median capsule position, using this to apply a
weighting factor to each capsule score. This was done
because it was noted that in the majority of healthy
volunteers the transit marker capsules travelled along
the gut as a group, but in some volunteers a few capsules
separated substantially from the group, which heavily
affects a simplemeanposition score.Although theuseof
the weighting factor for the MRI marker capsule scores
made only a small change to the averagemedian capsule
position unit, 0.97 (non-weighted) vs 0.8 (weighted), it
made a larger change to the longer transit times. Using
the weighted score improved the Spearman’s rank
correlation coefficient with the ROM method from 0.7
(p < 0.0001) for non-weighted to 0.85 (p < 0.0001) for
weighted.
A previous MRI feasibility study used five small
eppendorf tubes filled with a Gd-DPTA/saline solution
as markers of transit19 which gave an estimated colonic
transit time of 41  9 h in women and 31  10 h in
men, although their methodology and analysis were
different from ours making direct comparison difficult.
Our study builds on this previous study by designing a
capsule which could be transferable to clinical practice,
comparing the method against the widely used ROM
method and usingwidely availableMRI scans at a single
24 h time point instead of six time points over 60 h as in
their method. The optimum assessment period (24 h vs
48 h) for measuring colonic transit has been evaluated
for the scintigraphicmethodwhere a single dose is given
and colonic transit assessed,20 which was a similar
method to the one described here. This showed the
lowest short-term intra-subject variation at 24 h. How-
ever, other studies suggested that 48 h does better
especially for slower transits.21 It would be worthwhile
and easy in future studies to include a 48 h scan to
address this point.
We found a strong correlation between the WGT
measured by MRI and the ROM method. Previous
studies suggest that ROMs which are typically 2 mm
diameter and the MRI marker capsules which are
much larger (20 9 7 mm) may travel through the
different regions of the gut at different rates. Previous
work indicates that small pellets <2 mm diameter
empty from the stomach during the digestive phase,
whilst large capsules will empty more slowly after a
meal, emptying during phase III of the MMC.22,23 This
is supported by more recent studies comparing empty-
ing of scintigraphic liquid phase markers given with a
Table 1 Correlations between MRI parameters and patient
demographics
OCTT (min)* WGT (h)†
Age rs = 0.36
p = 0.02
rs = 0.08
p = 0.61
Height (m) rs = 0.04
p = 0.81
rs = 0.11
p = 0.50
Weight (kg) rs = 0.09
p = 0.56
rs = 0.21
p = 0.18
BMI (kg/m2) rs = 0.13
p = 0.41
rs = 0.23
p = 0.14
Anxiety score rs = 0.29
p = 0.08
rs = 0.13
p = 0.42
Depression score rs = 0.15
p = 0.38
rs = 0.16
p = 0.31
Total colonic volume
at t360 (mL)
rs = 0.26
p = 0.10
rs = 0.16
p = 0.33
Ascending colon volume
at t360 (mL)
rs = 0.27
p = 0.08
rs = 0.03
p = 0.86
Transverse colon volume
at t360 (mL)
rs = 0.02
p = 0.89
rs = 0.13
p = 0.42
Descending colon volume
at t360 (mL)
rs = 0.29
p = 0.07
rs = 0.17
p = 0.27
Δ t405-t360 Total colon
volume (mL)
rs = 0.07
p = 0.66
rs = 0.02
p = 0.91
Δ t405-t360 Ascending colon
volume (mL)
rs = 0.19
p = 0.23
rs = 0.10
p = 0.90
Δ t405-t360 Transverse colon
volume (mL)
rs = 0.11
p = 0.50
rs = 0.16
p = 0.31
Δ t405-t360 Descending colon
volume (mL)
rs = 0.04
p = 0.81
rs = 0.13
p = 0.43
Fasted SBWC (mL) rs = 0.17
p = 0.28
rs = 0.08
p = 0.61
AUC SBWC (mL/min) rs = 0.01
p = 0.97
rs = 0.08
p = 0.65
rs=Spearman’s rank correlation coefficient.
*Orocecal transit time (OCTT) measured using the Lactose Ureide
breath test (LUBT).
†Whole gut transit time (WGT) measured using MRI marker capsules.
© 2013 The Authors.
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solid meal with a 25 9 12 mm wireless motility
capsule.24 However, once in the small bowel and
mixed with chyme, movement is unaffected by dosage
form.25,26 Although it has been suggested that larger
capsules will move ahead of smaller pellets in the
colon,27 the similar WGT values seen with ROMs
(29.7 h [IQR 22.4–45.7 h]) and the wireless motility
capsules suggest that these minor differences do not
significantly alter the final result28 and the values
obtained for WGT were similar to those we observed.
Previous animal studies suggested that when pills are
fed with food, a pill density of 1.0 was associated with
fastest transit and pills with a density greater than or
less than 1.0 emptied more slowly.29 Human studies
showed that, when taken fasting, pills with an
extremely high density (2.4 g/cm3) empty slower than
those with a density of 1.5 g/cm3 but lower densities
were not evaluated.30,31 However, densities less that
1.0 would be expected to float as we have shown for
lipids,32 and hence have delayed emptying.
Our imaging technique allows us to easily assess the
position of themarkers and assign accurately to upper or
lower half of the ascending, transverse, and descending
colonwhich increases accuracy compared with less fine
grainedassessment.However, thesigmoid ismuchmore
convoluted, divided into small segments and hence it is
difficult to assign markers with such precision so we
have grouped the sigmoid and rectum together.
As others have reported33 we found that reproduc-
ibility for WGT was better than for OCTT with an ICC
value of 0.69 (p < 0.001) for the ROM method and 0.61
(p = 0.001) for the MRI marker capsule method.
We were also interested to see if we could develop a
purely MRI based method to quantify both WGT and
OCTT so we also assessed the OCTT using MRI and
compared it with the LUBT. The median OCTT value
we measured using the LUBT was 225 min (IQR 165–
278 min), which is slightly faster compared with the
value of 292  58 min quoted in a study where the
LUBT was validated against scintigraphy but the meal
used which consisted of one scrambled egg and two
slices of bread was smaller than ours which may
account for the differences.14 We found ICC values for
repeat measurements of LUBT and MRI were both low
at 0.35 (p = 0.058) and 0.46 (p = 0.017), suggesting
OCTT depends on variables which were not easily
controlled as others have reported.21 Since the extent of
individual variability is similar for both techniques
this suggests the variability reflects intrinsic biological
variability rather than methodological variability.33
There have been many attempts to develop measure-
ments of OCTT. The lactulose breath hydrogen test has
been widely used in the past34 but it is known that the
osmotic effect of the unabsorbable lactulose accelerates
transit when compared with scintigraphy making it
unsuitable as an assessment. Furthermore, interpreta-
tion of breath hydrogen is complex in precisely the
conditions when small bowel transit is likely to be
abnormal, since bacterial overgrowth is common and
would give a spuriously short OCTT value. Unfortu-
nately this is also likely to be true for the LUBT which,
however, does not alter transit in the way that lactulose
does, as the dose used is so small. TheWirelessMotility
Capsule (SmartPill GI Monitoring System, the Smart-
Pill Corporation, Buffalo,NY,USA)35 can also be used to
assess OCTT measured from the time the pH rises on
entering the duodenum to the time it falls on entering
the colon. AmedianOCTTof 276 minwas reported in a
study using the standard eggbeatermeal (194 Kcal).35 Its
use is limited by cost but also in conditions of small
bowel disease associated with narrowing (Crohn’s dis-
ease, radiation ileitis etc.) when there is a risk of the pill
getting stuck in the narrowing. A recent review
concludes that scintigraphy is probably the best assess-
ment of OCTT in clinical practice but warns that the
technique is not standardized and the normal range is
wide, a severe limitation of this test.3
Our MRI based technique for measuring the OCTT
has been described previously and involves looking for
the arrival of the high intensity head of a 362 Kcal rice
pudding meal in the cecum.11 We obtained a median
OCTT value of 225 min (IQR 180–270 min) for the
same test meal using this new approach, which is in
very close agreement with values reported previously
using this method.11 Although we report the same
median OCTT values using LUBT and MRI, with
similar ranges, our results showed poor agreement
between the two methods (Fig. 5B). One limitation to
our MRI technique compared with the LUBT is that
due to cost we were limited to scanning every 45 min,
while we sampled every 10–15 min for the breath test.
Another important consideration was that on occa-
sions it was difficult to interpret the arrival of the head
of the meal on the MRI images, particularly in cases
where bright residues appeared in the cecum before or
soon after eating the rice pudding meal which could
cause confusion with the later actual arrival of the
head of the meal. We compared two observers and
showed weak agreement between measurements with
an ICC of 0.44 (p = 0.002) suggesting that this would
not be a useful measure as it depended too much on
observer characteristics.
Bycontrast theMRImarker capsulemethoddescribed
is simple, involving just one visit for a set of MRI scans
which takes round 5 min to perform and which are
easily interpreted due to the detailed anatomical infor-
© 2013 The Authors.
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mation provided. The MRI scans used are not specialist
research scans but ones commonly available on most
clinical MRI scanner platforms. We believe for these
reasons that it could be widely adopted. Using our
algorithm the results of the test given in hours would be
very simple to interpret by the clinician andweobserved
strong inter-observer agreement between measure-
ments using this methods, with an ICC of 0.78
(p < 0.001). Although in this study we used a 3 T MRI
scanner to visualize the capsules at 24 h, we have
recently shown that that method can also be used with
1.5 T MRI scanners (RC Spiller, unpublished data), and
performed concurrently with the MRI OCTT method
described, making the combined test easily transferable
to hospital use. Moreover, as the T1 weighted 3D TFE
sequence does not require the use of a dedicated torso
coil to receive the RF signal, this further increases the
portability and simplicity of the method for use in
clinical practice. A dedicated torso coil can be used to
acquire additional images which can be converted into
rotating movies and these provide good spatial resolu-
tion which can be useful for further confirmation of the
exact position of a capsule. The sequences used are
available on all currentMRI scanners and scanning time
is very short at around 5 min. Since the images are easy
to interpret a trained physicist could and does report the
scans. The cost of MRI scanning is falling and if the test
avoids the use of other investigationsmight well be cost
effective. Our method has the advantage that we can
simultaneously measure colonic transit and SBWC
whichwill be usefulwhen extending it to use in patients
with various GI disorders of gastrointestinal function. It
is non-invasive, highly patient acceptable and does not
expose the patient to ionizing radiation allowing its use
in young women and children, a group in whom
constipation is common and assessment of transit often
clinically useful.
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SUPPORTING INFORMATION
Additional Supporting Information may be found in the online version of this article:
Video S1. Representative example of rotating MRI movie showing five MRI marker capsules in the colon of a
healthy volunteer 24 h after ingestion.
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